Cargando…
Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis Vaccine
An Aspergillus fumigatus vaccine based on recombinant Asp f3-protein has the potential to prevent aspergillosis in humans, a devastating fungal disease that is the prime obstacle to the success of hematopoietic cell transplantation. This vaccine protects cortisone acetate (CA)-immunosuppressed mice...
Autores principales: | Diaz-Arevalo, Diana, Ito, James I., Kalkum, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441197/ https://www.ncbi.nlm.nih.gov/pubmed/23024640 http://dx.doi.org/10.3389/fmicb.2012.00299 |
Ejemplares similares
-
The secreted FolAsp aspartic protease facilitates the virulence of Fusarium oxysporum f. sp. lycopersici
por: Wang, Chenyang, et al.
Publicado: (2023) -
Cytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells?
por: Thakur, Raman, et al.
Publicado: (2015) -
Characterization of a lytic Pseudomonas aeruginosa phage vB_PaeP_ASP23 and functional analysis of its lysin LysASP and holin HolASP
por: Cui, Jiaqi, et al.
Publicado: (2023) -
The Crystal Structure of Peroxiredoxin Asp f3 Provides Mechanistic Insight into Oxidative Stress Resistance and Virulence of Aspergillus fumigatus
por: Hillmann, Falk, et al.
Publicado: (2016) -
Rapamycin Improves the Response of Effector and Memory CD8(+) T Cells Induced by Immunization With ASP2 of Trypanosoma cruzi
por: Moraschi, Barbara Ferri, et al.
Publicado: (2021)